1Barondes S H, Cooper D N, Gitt M A, et al. Galectins. Structure and function of a large family of animal lectins[J]. J Biol Chem,1994,269(33): 20807 -20810.
2Perillo N L, Marcus M E, Baum L G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death [ J ].J Mol Med, 1998, 76(6) : 402 -412.
3Yoshii I, Inohara H, Takenaka Y, et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells[ J]. Int J Oncol,2001, 18(4) : 787 -792.
4Hsu D K, Liu F T. Regulation of cellular homeostasis by galectins [J]. Glycoconl J, 2004,19(7-9) : 507 -515.
5Matarrese P, Fusco O, Tinari N, et al. Galectin-3 overexpression protects from apeptosis by improving cell adhesion properties [ J ].Int J Cancer, 2000, 85(4) : 545 -554.
6Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis[J]. Am J Pathol, 2000, 156(3): 899-909.
7Yoshii T, Fukumori T, Honjo Y, et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest [J]. J Biol Chore, 2002, 277(9) : 6852 -6857.
8Parise L V, Lee J, Juliano R L. New aspects of integrin signaling in cancer[J]. Semin Cancer Biol, 2000, 10(6) : 407 -414.
9Xu X C, el-Naggar A K, Lotan R, et al. Differenlal expression of galeetin-1 and galectin-3 in thyroid tumors. Potential dignostic implications[J]. Am J Pathol, 1995, 147(3) : 815 -822.
10Fermamdez P L, Merino M J. Gomez M, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue [J]. J Pathol, 1997, 181(1): 80-86.
6Kopf B, Rosti G, Lanzanova G, et al. Locally advanced ovarian carcinoid [J]. Exp Clin Cancer Res,2005,24(2) :313-316.
7Matsuda K, Maehama T, Kanazawa K. Strumal carcinoid tumor of the ovary: a case exhibiting severe constipation associated with PYY [J]. Gynecol Oncol,2002,87( 1 ) :143-145.
